A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion

被引:10
|
作者
Fichter, Christiane Daniela [1 ,2 ,3 ]
Przypadlo, Camilla Maria [1 ,2 ]
Buck, Achim [4 ]
Herbener, Nicola [1 ,2 ]
Riedel, Bianca [1 ,2 ]
Schaefer, Luisa [1 ,2 ]
Nakagawa, Hiroshi [5 ]
Walch, Axel [4 ]
Reinheckel, Thomas [2 ,6 ,7 ,8 ,9 ,10 ]
Werner, Martin [1 ,2 ,7 ,9 ,10 ]
Lassmann, Silke [1 ,2 ,3 ,7 ,8 ,9 ,10 ]
机构
[1] Univ Freiburg, Inst Surg Pathol, Med Ctr, Breisacherstr 115a, D-79106 Freiburg, Germany
[2] Univ Freiburg, Fac Med, Freiburg, Germany
[3] Univ Freiburg, Fac Biol, Freiburg, Germany
[4] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, Neuherberg, Germany
[5] Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
[6] Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany
[7] Univ Freiburg, Comprehens Canc Ctr Freiburg, Med Ctr, Freiburg, Germany
[8] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany
[9] German Canc Consortium DKTK, Partner Site Freiburg, Heidelberg, Germany
[10] German Canc Res Ctr, Heidelberg, Germany
来源
JOURNAL OF PATHOLOGY | 2017年 / 243卷 / 04期
关键词
oesophageal cancer; ErbB homodimers; ErbB heterodimers; non-apoptotic blebbing; cell migration; cell invasion; HER-2/NEU GENE AMPLIFICATION; PROTEIN OVEREXPRESSION; IN-VITRO; CANCER; EXPRESSION; MIGRATION; EGFR; ASSOCIATION; CARCINOMA; P63;
D O I
10.1002/path.4987
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oesophageal squamous cell carcinomas and oesophageal adenocarcinomas show distinct patterns of ErbB expression and dimers. The functional effects of specific ErbB homodimers or heterodimers on oesophageal (cancer) cell behaviour, particularly invasion during early carcinogenesis, remain unknown. Here, a new cellular model system for controlled activation of epidermal growth factor receptor (EGFR) or human epidermal growth factor receptor 2 (HER2) and EGFR-HER2 or HER2-human epidermal growth factor receptor 3 (HER3) homodimers and heterodimers was studied in non-neoplastic squamous oesophageal epithelial Het-1A cells. EGFR, HER2 and HER3 intracellular domains (ICDs) were fused to dimerization domains (DmrA/DmrA and DmrC), and transduced into Het-1A cells lacking ErbB expression. Dimerization of EGFR, HER2 or EGFR-HER2 and HER2-HER3 ICDs was induced by synthetic ligands (A/A or A/C dimerizers). This was accompanied by phosphorylation of the respective EGFR, HER2 and HER3 ICDs and activation of distinct downstream signalling pathways, such as phospholipase C1, Akt, STAT and Src family kinases. Phenotypically, ErbB dimers caused cell rounding and non-apoptotic blebbing, specifically in EGFR-HER2 and HER2-HER3 heterodimer cells. In a Transwell assay, cell migration velocity was elevated in HER2 dimer cells as compared with empty vector cells. In addition, HER2 dimer cells showed in increased cell invasion, reaching significance for induced HER2-HER3 heterodimers (P=0.015). Importantly, in three-dimensional organotypic cultures, empty vector cells grew as a superficial cell layer, resembling oesophageal squamous epithelium. In contrast, induced HER2 homodimer cells were highly invasive into the matrix and formed cell clusters. This was associated with partial loss of cytokeratin 7 (when HER2 homodimers were modelled) and p63 (when EGFR-HER2 heterodimers were modelled), which suggests a change or loss of squamous cell differentiation. Controlled activation of specific EGFR, HER2 and HER3 homodimers and heterodimers caused oesophageal squamous epithelial cell migration and/or invasion, especially in a three-dimensional microenvironment, thereby functionally identifying ErbB homodimers and heterodimers as important drivers of oesophageal carcinogenesis. Copyright (c) 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:481 / 495
页数:15
相关论文
共 50 条
  • [1] The human epidermal growth factor receptor 2 (HER2)
    Tafe, Laura J.
    Tsongalis, Gregory J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (01) : 23 - 30
  • [2] Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: Quantitative analysis of HER2 overexpression effects
    Hendriks, BS
    Opresko, LK
    Wiley, HS
    Lauffenburger, D
    CANCER RESEARCH, 2003, 63 (05) : 1130 - 1137
  • [3] Human epidermal growth factor receptor 2 (HER2) and the future of bladder carcinoma
    Sarkis, Julien
    Alkassis, Marwan
    Assaf, Joy
    ARAB JOURNAL OF UROLOGY, 2020, 18 (04) : 273 - 274
  • [4] Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas
    Clauditz, Till Sebastian
    Reiff, Maren
    Gravert, Linn
    Gnoss, Alexander
    Tsourlakis, Maria-Christina
    Muenscher, Adrian
    Sauter, Guido
    Bokemeyer, Carsten
    Knecht, Rainald
    Wilczak, Waldemar
    PATHOLOGY, 2011, 43 (05) : 459 - 464
  • [5] Targeting human epidermal growth factor receptor 2 (HER2) in gynecologic malignancies
    Erickson, Britt K.
    Zeybek, Burak
    Santin, Alessandro D.
    Fader, Amanda N.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2020, 32 (01) : 57 - 64
  • [6] Clinical impact of epidermal growth factor receptor (EGFR) coexpression in early breast cancer with human epidermal growth factor receptor 2 (HER2) overexpression
    Park, S.
    Cho, E.
    Shin, Y.
    Hong, S.
    Lee, M.
    Park, Y.
    Nam, S.
    Yang, J.
    Choi, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] A human epidermal growth factor receptor 3 (HER3)-binding nanoparticle targets and kills Herceptin®-resistant human epidermal growth factor receptor 2 (HER2)-positive breast cancer
    Sims, J. D.
    Taguaim, M.
    Hanson, C.
    Cui, X.
    Medina-Kauwe, L. K.
    CANCER RESEARCH, 2013, 73
  • [8] Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)
    Siddiqui, Mohammad R.
    Railkar, Reema
    Sanford, Thomas
    Crooks, Daniel R.
    Eckhaus, Michael A.
    Haines, Diana
    Choyke, Peter L.
    Kobayashi, Hisataka
    Agarwal, Piyush K.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)
    Mohammad R. Siddiqui
    Reema Railkar
    Thomas Sanford
    Daniel R. Crooks
    Michael A. Eckhaus
    Diana Haines
    Peter L. Choyke
    Hisataka Kobayashi
    Piyush K. Agarwal
    Scientific Reports, 9
  • [10] Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target
    De Vita, F.
    Giuliani, F.
    Silvestris, N.
    Catalano, G.
    Ciardiello, F.
    Orditura, M.
    CANCER TREATMENT REVIEWS, 2010, 36 : S11 - S15